Top CRO Companies to Watch Out for in 2023/2024: Parexel, Syneos Health, ICON plc, & PSI CRO AG
Who's paving the way in CRO?
Clinical research organisations (CROs) play a crucial role in drug development, assisting pharmaceutical and biotech companies in bringing new treatments to market. As the demand for clinical trials continues to rise, CROs are experiencing significant growth and expanding their capabilities. In this blog, we will take a closer look at four CRO companies to watch out for in 2023/2024: Parexel, Syneos Health, ICON plc, and PSI CRO AG.
Parexel is a leading CRO that offers a wide range of services, including clinical research, regulatory consulting, and market access. With a presence in over 100 countries and more than 20,000 employees, Parexel has established itself as a trusted partner for pharmaceutical and biotech companies around the world.
In recent years, Parexel has focused on expanding its digital capabilities, investing in technologies like artificial intelligence (AI) and machine learning (ML) to improve the efficiency and accuracy of clinical trials. The company has also been actively involved in COVID-19 research, providing support for vaccine development and clinical trials.
As the demand for digital solutions in clinical trials continues to grow, Parexel is well-positioned to capitalise on this trend and maintain its leadership position in the CRO industry.
Key Points:
⚈𝟏𝟎% 𝐘𝐎𝐘 headcount growth ⚈ Average employee tenure of around 4 years ⚈ 18,996 employees worldwide
Syneos Health is a CRO that specialises in integrated solutions, combining clinical development, commercialisation, and consulting services. The company has a global footprint, with operations in over 50 countries and more than 25,000 employees.
In recent years, Syneos Health has been actively involved in digital transformation initiatives, developing new technologies and solutions to improve the speed and efficiency of clinical trials. For example, the company has developed a digital platform that enables remote monitoring of patients and real-time data analysis.
Syneos Health has also been at the forefront of COVID-19 research, providing support for vaccine development and clinical trials. As the demand for integrated solutions and digital technologies in clinical trials continues to increase, Syneos Health is well-positioned to capitalise on these trends and continue its growth trajectory.
Key Points:
⚈𝟓% 𝐘𝐎𝐘 headcount growth ⚈ Average employee tenure of 2 years ⚈ 22,536 employees globally
ICON plc is a CRO that offers a broad range of services, including clinical research, consulting, and technology solutions. With a presence in over 40 countries and more than 16,000 employees, ICON plc has established itself as a leader in the CRO industry.
In recent years, ICON plc has focused on developing new technologies and solutions to improve the efficiency and accuracy of clinical trials. For example, the company has developed a digital platform that enables remote monitoring of patients and real-time data analysis. ICON plc has also been actively involved in COVID-19 research, providing support for vaccine development and clinical trials.
As the demand for digital solutions and technology-driven approaches in clinical trials continues to grow, ICON plc is well-positioned to capitalise on these trends and maintain its leadership position in the CRO industry.
Key Points:
⚈ 𝟔% 𝐘𝐎𝐘 headcount growth ⚈ Average employee tenure of around 2 years ⚈ 34,203 employees worldwide
PSI CRO AG is a CRO that specialises in clinical research and data management. The company has a global presence, with operations in over 60 countries and more than 2,000 employees.
In recent years, PSI CRO AG has focused on developing new technologies and solutions to improve the efficiency and accuracy of clinical trials. For example, the company has developed a digital platform that enables remote monitoring of patients and real-time data analysis. PSI CRO AG has also been actively involved in COVID-19 research, providing support for vaccine development and clinical trials.
As the demand for digital solutions and data management services in clinical trials continues to grow, PSI CRO AG is well-positioned to capitalise on these trends and expand its market share in the CRO industry.
Key Points:
⚈𝟗% 𝐘𝐎𝐘 headcount growth ⚈ Average employee tenure of around 3.5 years ⚈ 1,983 employees globally
Well worth keeping your eyes on over the coming years! Who do you have your eyes locked on for 2023-2024?
